Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06627374

Study of Thoracic Ultrasound As a Response to the Closure of Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants

The Predictive Value of Thoracic Ultrasound As a Response to the Closure of Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants: an Observational Pilot Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
28 Days
Healthy volunteers
Not accepted

Summary

The diagnostic hypothesis is based on the evidence that, while the functional closure of the PDA (Patent Ductus Arteriosus) occurs within a few hours after birth, anatomical closure may take several weeks. The functional closure of the PDA can be extremely sensitive to variations in blood oxygen tension and the hemodynamic instability of preterm infants. Therefore, echocardiographic evaluation and ductal diameter at a single point in time (such as during PDA echocardiography) may not correlate with transductal blood flow. Assessing the variation in the amount of pulmonary interstitial fluid using LUS (lung ultrasound score) could be an early predictive parameter for the closure or non-closure of hsPDA (hemodynamically significant PDA).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPatent Ductus Arteriosus in neonatesNeonates admitted to Neonatal care Unit after birth, undergoing hsPDA (hemodynamically significant Patent Ductus Arteriosus) closure according to standard clinical practice, will be included.

Timeline

Start date
2024-09-20
Primary completion
2026-09-30
Completion
2026-09-30
First posted
2024-10-04
Last updated
2024-10-15

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06627374. Inclusion in this directory is not an endorsement.